Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infective APIs and finished dosage forms (FDFs). With over 120 years of pharmaceutical manufacturing heritage, they supply APIs and sterile injectables to over 500 pharmaceutical companies across 80 countries. Also operates as a CMO for third-party sterile injectable production.
World leader in fermentation-based manufacturing of anti-infective APIs (vancomycin, daptomycin, colistimethate, etc.), aseptic injectable filling, and CMO services for complex sterile drug products.
4 sites worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.